NYSE:ZTS - Zoetis Stock Price, News & Analysis

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

Zoetis announced a quarterly dividend on Thursday, May 16th. Shareholders of record on Friday, July 19th will be given a dividend of $0.164 per share on Tuesday, September 3rd. This represents a $0.66 annualized dividend and a yield of 0.53%. The ex-dividend date is Thursday, July 18th. View Zoetis' Dividend History.

Zoetis declared that its board has approved a share buyback program on Wednesday, December 12th 2018, which permits the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 4.7% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's leadership believes its stock is undervalued.

Zoetis Inc (NYSE:ZTS) released its quarterly earnings results on Tuesday, August, 6th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.82 by $0.08. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.51 billion. Zoetis had a return on equity of 72.86% and a net margin of 22.74%. The business's revenue was up 9.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 earnings per share. View Zoetis' Earnings History.

Zoetis is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Zoetis.

Zoetis updated its FY19 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of $3.53-3.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.49. The company issued revenue guidance of $6.18-6.28 billion, compared to the consensus revenue estimate of $6.19 billion.

14 brokerages have issued twelve-month price targets for Zoetis' stock. Their predictions range from $86.00 to $138.00. On average, they anticipate Zoetis' stock price to reach $115.2857 in the next year. This suggests that the stock has a possible downside of 7.1%. View Analyst Price Targets for Zoetis.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zoetis in the last year. There are currently 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zoetis.

News articles about ZTS stock have trended positive recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Zoetis earned a news sentiment score of 2.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the next few days. View News Stories for Zoetis.

Zoetis saw a increase in short interest in July. As of July 31st, there was short interest totalling 3,953,400 shares, an increase of 7.7% from the June 30th total of 3,670,400 shares. Based on an average trading volume of 2,000,000 shares, the short-interest ratio is presently 2.0 days. Currently, 0.8% of the shares of the stock are sold short. View Zoetis' Current Options Chain.

Some companies that are related to Zoetis include Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Pfizer (PFE), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Eli Lilly And Co (LLY), Sanofi (SNY), GlaxoSmithKline (GSK), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG) and Shire (SHPG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zoetis investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Transocean (RIG), Gran Tierra Energy (GTE) and Och-Ziff Capital Management Group (OZM).

Zoetis' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.68%), BlackRock Inc. (7.53%), BlackRock Inc. (7.51%), Morgan Stanley (2.78%), Polen Capital Management LLC (2.13%) and Nuveen Asset Management LLC (1.48%). Company insiders that own Zoetis stock include Catherine A Knupp, Clinton A Jr Lewis, Glenn David, Heidi C Chen, Juan Ramon Alaix, Khosla Sanjay, Kristin C Peck, Roman Trawicki, Roxanne Lagano and Willie M Reed. View Institutional Ownership Trends for Zoetis.

ZTS stock was sold by a variety of institutional investors in the last quarter, including BNP PARIBAS ASSET MANAGEMENT Holding S.A., BlackRock Inc., BlackRock Inc., Mackenzie Financial Corp, AQR Capital Management LLC, Marshall Wace LLP, Marshall Wace North America L.P. and Price T Rowe Associates Inc. MD. Company insiders that have sold Zoetis company stock in the last year include Catherine A Knupp, Clinton A Jr Lewis, Glenn David, Heidi C Chen, Juan Ramon Alaix, Kristin C Peck, Roman Trawicki, Roxanne Lagano and Willie M Reed. View Insider Buying and Selling for Zoetis.

ZTS stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Bank of New York Mellon Corp, Vanguard Group Inc., Natixis, Natixis, AKO Capital LLP, Ontario Teachers Pension Plan Board and CIBC Private Wealth Group LLC. View Insider Buying and Selling for Zoetis.

Shares of ZTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ZTS stock can currently be purchased for approximately $124.12.

Zoetis has a market capitalization of $59.27 billion and generates $5.83 billion in revenue each year. The company earns $1.43 billion in net income (profit) each year or $3.13 on an earnings per share basis. Zoetis employs 10,000 workers across the globe.View Additional Information About Zoetis.

The official website for Zoetis is http://www.zoetis.com/.

Zoetis' mailing address is 10 Sylvan Way, Parsippany NJ, 07054. The company can be reached via phone at 973-822-7000 or via email at [email protected]